RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1007%2Fs00432-012-1219-x

https://w3id.org/ripe/ripe-kg/work/10.1007%2Fs00432-012-1219-x
SubjectPredicateObject
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma prism:doi 10.1007/s00432-012-1219-x
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma dcterms:title Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma rdf:type node1
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma rdf:type rdfs:Resource
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma rdf:type owl:Thing
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma rdf:type prov:Entity
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma rdf:type ripe:WorkWork
ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma owl:sameAs https://semopenalex.org/work/W1981239587
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00432-012-1219-xComparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma